The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Treatments for addressing psychiatric mental health issues in vulnerable patients with cancer are established. Yet, many patients persist with unrelenting psychological difficulties despite intervention. There is growing interest in the role of psilocybin-assisted psychotherapy for managing treatment-resistant mental health challenges in patients with cancer. Psilocybin is a naturally occurring compound derived from certain mushroom species that can induce entheogenic experiences or an altered state of consciousness. Reed's Self-Transcendence Theory provides a holistic lens to examine existential concerns and mental health in individuals who perceive their illness as potentially life threatening, such as those with cancer. This scoping literature review used Arksey and O’Malley's template to evaluate research examining psilocybin-assisted psychotherapy for patients with cancer. Eight articles met inclusion/exclusion criteria (four quantitative, two mixed methods, and two qualitative). Review findings indicated that the majority of patient experiences were positive, centering on themes of death acceptance, reflection, and broadened spirituality. Although psilocybin-assisted psychotherapy is in early stages of clinical testing, it thus shows promise for carefully screened patients with cancer who have persistent existential suffering. It will be critical for investigators to tailor this emerging intervention to select patients and for clinicians to be engaged in assessment of outcomes and efficacy. © The Author(s) 2021.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of patient experiences were summarized as positive, centering on themes of death acceptance, reflection, and broadened spirituality”
From Psychosocial and Integrative Oncology: Interventions Across the Disease Trajectory. (2023) · cites this paper as Lehto et al. 2022
Citations
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
Scoping studies: towards a methodological framework
Arksey, H., & O'Malley, L. (2005) · International Journal of Social Research Methodology · doi:10.1080/1364557032000119616 · Cited by 36,742
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 5×
“Psilocybin-assisted therapy was found to modify depression and anxiety symptoms, sustained at 6 months and 3.2- and 4.5-year posttreatment (Agin-Liebes et al., 2020; Griffiths et al., 2016).”
BackgroundMethodInfluentialRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · cited 6×
“…bi n th er ap y he lp ed fa ci lit at e a fe lt re co nn ec ti on to lif e, a re cl ai m in g of pr es en ce ,a nd gr ea te r co nfi de nc e in th e fa ce of ca nc er re cu rr en ce 274 double-blind trials with 51 (Griffiths et al., 2016) and 29 participants (Ross et al., 2016), respectively.”
BackgroundMethodInfluentialPilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 5×
“Quantitative studies (n= 4): One quantitative study was a feasibility/acceptability pilot with 12 participants (Grob et al., 2011).”
BackgroundMethodInfluentialWatts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817709585 · Cited by 589 · cited 4×
“Studies evaluating the efficacy of psilocybin for managing treatment-resistant depression have also shown promising findings (Watts et al., 2017).”
BackgroundInfluentialGriffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., & Klinedinst, M. A. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117731279 · Cited by 520
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360 · cited 7×
“Psilocybin-assisted therapy was found to modify depression and anxiety symptoms, sustained at 6 months and 3.2- and 4.5-year posttreatment (Agin-Liebes et al., 2020; Griffiths et al., 2016).”
BackgroundMethodInfluentialBelser, A. B., Agin-Liebes, G., Swift, T. C., Terrana, S., Devenot, N., Friedman, H. L., Guss, J., Bossis, A., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817706884 · Cited by 311 · cited 3×
“Participants participated in in-depth semi-structured interviews (Belser et al., 2017; Swift et al., 2017).”
BackgroundAdvancing psychosocial care in cancer patients
Grassi, L., Spiegel, D., & Riba, M. (2017) · F1000Research · doi:10.12688/f1000research.11902.1 · Cited by 219
Swift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., Guss, J., Bossis, A. P., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817715966 · Cited by 195 · cited 3×
“Participants participated in in-depth semi-structured interviews (Belser et al., 2017; Swift et al., 2017).”
BackgroundPsilocybin: from ancient magic to modern medicine
Nichols, D. E. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0311-8 · Cited by 184
Byock, I. (2018) · Journal of Palliative Medicine · doi:10.1089/jpm.2017.0684 · Cited by 161
Bauereiß, N., Obermaier, S., Özünal, S. E., & Baumeister, H. (2018) · Psycho-Oncology · doi:10.1002/pon.4829 · Cited by 149
Ross, S., Agin-Liebes, G., Lo, S., Zeifman, R. J., Ghazal, L., Benville, J., Franco Corso, S., Bjerre Real, C., Guss, J., Bossis, A., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00020 · Cited by 139
Individual experiences in four cancer patients following psilocybin-assisted psychotherapy
Malone, T. C., Mennenga, S. E., Guss, J., Podrebarac, S. K., Owens, L. T., Bossis, A. P., Belser, A. B., Agin-Liebes, G., Bogenschutz, M. P., & Ross, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00256 · Cited by 131 · cited 4×
“The psilocybin journey helped The Role of Psilocybin-Assisted Psychotherapy to Support Patients with Cancer/Lehto et al. 275 patients reconcile and face the alienating traumatic and distressing experience of cancer and the realness of death (Malone et al., 2018).”
BackgroundMethodInfluentialKarlsson, M., Friberg, F., Wallengren, C., & Öhlén, J. (2014) · BMC Palliative Care · doi:10.1186/1472-684x-13-28 · Cited by 90
Global Perspectives on Palliative Care for Cancer Patients: Not All Countries Are the Same
Brant, J. M., & Silbermann, M. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01044-8 · Cited by 72
Reed, P. G. (2018) · Springer Publishing Company eBooks · doi:10.1891/9780826159922.0007 · Cited by 70
Zhai, J., Newton, J., & Copnell, B. (2019) · Health Care For Women International · doi:10.1080/07399332.2019.1578360 · Cited by 68
Penn, A., Phelps, J., Rosa, W. E., & Watson, J. (2021) · Journal of Humanistic Psychology · doi:10.1177/00221678211011013 · Cited by 48
CE: Psychedelic-Assisted Therapy
Penn, A., Dorsen, C. G., Hope, S., & Rosa, W. E. (2021) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000753464.35523.29 · Cited by 45
Healing with Plant Intelligence: A Report from Ayahuasca
Doyle, R. (2012) · Anthropology of Consciousness · doi:10.1111/j.1556-3537.2012.01055.x · Cited by 32
Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care
Rosa, W. E., Hope, S., & Matzo, M. (2019) · Journal of Holistic Nursing · doi:10.1177/0898010118770302 · Cited by 28 · cited 1×
“Ancient cultures have used plants and fungi capable of inducing altered states of consciousness (ASC) for healing, rituals and rites, and deathrebirth experiences throughout recorded history (Doyle, 2012; Rosa et al., 2019; Schultes & Hoffman, 1979).”
BackgroundSpiritual Perspectives on Pain in Advanced Breast Cancer: A Scoping Review
Flanigan, M., Wyatt, G. K., & Lehto, R. H. (2019) · Pain Management Nursing · doi:10.1016/j.pmn.2019.04.002 · Cited by 25
Self-citationPsilocybin for depression and anxiety associated with life-threatening illnesses
McCorvy, J. D., Olsen, R. H. J., & Roth, B. L. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675771 · Cited by 21
Emerging Psychedelic-Assisted Therapies: Implications for Nursing Practice
Denis-Lalonde, D., & Estefan, A. (2020) · Journal of Mental Health and Addiction Nursing · doi:10.22374/jmhan.v4i1.40 · Cited by 15
Johnson, R., Hauser, J. M., & Emanuel, L. L. (2020) · Palliative & Supportive Care · doi:10.1017/s1478951520000607 · Cited by 11
Lehto, R. H., Miller, S. E., Flanigan, M., & Wyatt, G. K. (2018) · Expert Review of Quality of Life in Cancer Care · doi:10.1080/23809000.2018.1483192 · Cited by 10
Self-citationFostering Nurse Engagement in Psychedelic-Assisted Therapies for Patients with Serious Illness
Rosa, W. E., Dorsen, C. G., & Penn, A. (2020) · Journal of Palliative Medicine · doi:10.1089/jpm.2020.0241 · Cited by 10
Psychopharmacological Agents for the Terminally Ill and Bereaved
Craytor, J. K., Goldberg, I. K., Malitz, S., & Kutscher, A. H. (1974) · AJN American Journal of Nursing · doi:10.2307/3469702 · Cited by 8
Psilocybin, Spirituality, and Palliative Care: Research and Implications
Bossis, A. P. (2021) · Alternative and Complementary Therapies · doi:10.1089/act.2020.29309.apb · Cited by 6
Research works printed but not linked: 2
- Kast E., 1966, The Quarterly, 26, 80
- Schultes R., 1979, Plants of the Gods
Cited by
Psychosocial and Integrative Oncology: Interventions Across the Disease Trajectory.
Carlson, L. E. (2023) · Annual Review of Psychology · doi:10.1146/annurev-psych-032620-031757 · Cited by 56
Psilocybin for clinical indications: A scoping review
Madden, K., Flood, B., Shing, D. Y., Ade‐Conde, A. M., Kashir, I., Mark, M., MacKillop, J. M., Bhandari, M., & Adili, A. F. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241269751 · Cited by 16
“A previous scoping review of psilocybin-assisted psychotherapy for cancer patients concluded that psilocybin is promising but that the field is in its early stages (Lehto et al., 2021).”
BackgroundMiller, M., Rosa, W. E., Rinaldi, A. D., Addicott, K., Spence, D., & Beaussant, Y. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2022.0009 · Cited by 12
“1,4–6 for a thorough review), the nascent field of modern PAT may be challenged to integrate into main-stream health systems and the Western biomedical model.”
Self-citationSchuitmaker, N. (2023) · Research Society and Development · doi:10.33448/rsd-v12i9.43308 · Cited by 5
“This is in line with prior research that hypothesises that a transcendental experience contributes to positive therapeutic outcomes (Grof, 2019; Lehto et al., 2022).”
ResultGarcia, A. C. M., Maia, L. O., & Reed, P. G. (2024) · Journal of Holistic Nursing · doi:10.1177/08980101241257836 · Cited by 9
“Lehto et al. (2022) conducted a scoping review to assess the available evidence on the use of psilocybin-assisted psychotherapy for the management of mental health symptoms and addressing existential concerns among cancer patients from the perspective of Reed ’ s (2024) Theory of Self-Transcendence.”
Metadata
- Authors
- Lehto, R. H., Miller, M., & Sender, J.
- Affiliations
- Michigan State University (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Lehto, Rebecca H.
- Venue
- Journal of Holistic Nursing
- Publisher
- SAGE Publications
- Published
- 2021-09-06
- Volume
- 40
- Issue
- 3
- Pages
- 265-280
- ISSN
- 0898-0101 (ISSN-L)
- 1552-5724
- OpenAlex
- W3196833323
- Semantic Scholar
- 0d8bd99ad0530b448e8c8ccf1fdd65ab93afb8a1
- Cited by
- 17
- References
- 33
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 1
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-11-18)
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Holistic Nursing (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psilocybin-assisted therapy, cancer patients, existential suffering, self-transcendence, death acceptance, spirituality, entheogens, altered states of consciousness, psychological distress in cancer patients
- MeSH terms
- Anxiety, Humans, Mental Health, Neoplasms, Psilocybin, Psychotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.